Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies. - Wikidata - wikimedia - TriplyDB

Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies.

Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies.

http://www.wikidata.org/entity/Q36375924

about

Surgery for Colorectal Cancer - Trends, Developments, and Future Perspectives Evolution of management in peritoneal surface malignancies Adhesion molecules in peritoneal dissemination: function, prognostic relevance and therapeutic options Abdominal metastases from colorectal cancer: intraperitoneal therapy Colorectal cancer: Metastases to a single organ The Mesothelial Origin of Carcinoma Associated-Fibroblasts in Peritoneal Metastasis Role of multi-modality therapy in peritoneal carcinomatosis and visceral metastasis: a case report and review of the literature Role of surgery in colorectal cancer liver metastases Cell-cell and cell-matrix dynamics in intraperitoneal cancer metastasis Targeting cancer using cholesterol conjugates Molecular biomarkers for the detection of metastatic colorectal cancer cells Pathophysiology of colorectal peritoneal carcinomatosis: Role of the peritoneum Catumaxomab: clinical development and future directions Preparation of anti-tumor nanoparticle and its inhibition to peritoneal dissemination of colon cancer Strategies to prevent peritoneal carcinomatosis arising from colorectal cancer.Brain-derived neurotrophic factor (BDNF)-induced tropomyosin-related kinase B (Trk B) signaling is a potential therapeutic target for peritoneal carcinomatosis arising from colorectal cancer Exosomal microRNAs isolated from plasma of mesenteric veins linked to liver metastases in resected patients with colon cancer.Evaluation of best supportive care and systemic chemotherapy as treatment stratified according to the retrospective peritoneal surface disease severity score (PSDSS) for peritoneal carcinomatosis of colorectal origin.Water: a simple solution for tumor spillage.Fluorescent detection of peritoneal metastasis in human colorectal cancer using 5-aminolevulinic acid Anaesthesia in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: retrospective analysis of a single centre three-year experience.Iterative cytoreductive surgery associated with hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis of colorectal origin with or without liver metastases.CTHRC1 is associated with peritoneal carcinomatosis in colorectal cancer: a new predictor for prognosis.Understanding molecular mechanisms in peritoneal dissemination of colorectal cancer : future possibilities for personalised treatment by use of biomarkers.Peritoneal carcinomatosis of colorectal origin.The trifunctional antibody catumaxomab in treatment of malignant ascites and peritoneal carcinomatosis.Systemic effect of catumaxomab in a patient with metastasized colorectal cancer: a case report.Evaluation of the efficacy of peritoneal lavage with distilled water in colorectal cancer surgery: in vitro and in vivo study.Gene therapy using therapeutic and diagnostic recombinant oncolytic vaccinia virus GLV-1h153 for management of colorectal peritoneal carcinomatosis Morbidity and mortality of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: national cancer institute, Mexico city, Mexico.Gastrointestinal perforation in metastatic colorectal cancer patients with peritoneal metastases receiving bevacizumab TRAIL gene-armed oncolytic poxvirus and oxaliplatin can work synergistically against colorectal cancer.A Phase II Study of Modified FOLFOX4 for Colorectal Cancer Patients with Peritoneal Carcinomatosis.Intraperitoneal chemotherapy as adjuvant treatment to prevent peritoneal carcinomatosis of colorectal cancer origin: a systematic review.Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841.Major clinical research advances in gynecologic cancer in 2011.A tumor-penetrating peptide enhances circulation-independent targeting of peritoneal carcinomatosis.BEV-IP: Perioperative chemotherapy with bevacizumab in patients undergoing cytoreduction and intraperitoneal chemoperfusion for colorectal carcinomatosis.Oral gastrografin radiography for the evaluation of the functional impact of peritoneal carcinomatosis: Correlation with clinicopathological findings.Prevention of Peritoneal Metastases from Colon Cancer in High-Risk Patients: Preliminary Results of Surgery plus Prophylactic HIPEC.

P2860

Q26738796-AD3BDE7A-BDF3-4900-B78B-191C22642C16 Q26741293-6FF21C73-99E0-4DAA-9AE3-59EC0F979FC5 Q26748666-26EA0CB9-64E4-4A8D-94EB-F06F00FD1E7C Q26772268-FE4FEFA5-F7A6-41A1-AEEF-88BF5A55B07D Q26778009-F217DBB6-7439-4BB0-A15A-08C412D370F0 Q26783022-D373D7E9-C022-427E-80FA-178651D0697C Q26799152-74738F83-8749-4874-83A3-9D0E5CD51F1A Q26830444-AA5F90E3-DDD3-472B-B6F2-525D06B6A614 Q26851836-F4FACC35-B38D-42F4-A636-AD8D2A8E935A Q26860103-EDDC209F-B81F-4471-A95C-BE0767AAEC6B Q27002450-643C735F-3000-4886-8732-AF5F94403083 Q28073129-78F46344-C137-4FC1-BAF9-5FCB00F7C0B2 Q28274519-69286DA7-8C49-4566-B336-71D6E519860E Q28539347-604A01FF-84EF-4A55-997E-C6E43370CCFB Q30239825-CB9D95B8-176A-42BF-B78C-03BAFA97006F Q33572980-886B1FBB-7145-41D3-B9B8-2CDCE4437F65 Q33761570-8B0139F2-DE1A-406D-96B7-FEFEF575837F Q33777576-48FC6BFA-14D9-4BA8-8FFC-610231DE429A Q33814391-39BC265E-1470-4CA0-AEF4-137149594E0A Q33836480-AD918B58-E7C4-4A14-8D65-D73DBE658766 Q33960679-F74C395A-1362-4154-9B05-44D0CA18FD9D Q34003396-D0446641-B599-4246-AA78-89FE49273E2F Q34325001-3B582E15-DE93-4D5A-8778-B3E6F22D2D23 Q34348691-E93E34A9-0851-43EE-BA3D-6277D191D4E2 Q34391090-31F7FFFB-8248-47EF-BBBF-729186489AA1 Q34624096-E86FC873-C016-4FB4-8539-B9C0E9C2E815 Q35079157-59A8DF0A-870F-4BDA-A113-0DBB688B19B4 Q35183465-B383EF19-9EF6-45E0-9485-1E6AD1567561 Q35216296-42E76BDE-9A09-4ACF-8439-394C6FC725AD Q35412031-69517B34-04F1-4DA5-9242-735918145BDD Q35567689-956F677C-8C8E-447A-8BBB-F892C8F93BD0 Q35647212-0A23734E-C908-4E17-A52F-5C0F84998E88 Q35661054-E9D1BDFA-E946-4EFB-98AA-5229C935D602 Q35678364-A1DC5661-5B1A-45EB-8A6D-89DADC9CED57 Q35721069-29746581-01DA-4F67-8E12-4D3321E23CE1 Q35758722-975C59E4-C269-4D6F-8C3B-798A0D04D9D9 Q35868066-4BAD85A2-68A0-4FD0-8DD3-B3E1B6073EE3 Q35870363-94234B8A-B6D8-4F8B-9B82-07279E3ACF85 Q35954086-BAABAA3A-398C-4A3C-B00E-BD6DA735C852 Q35974935-C7FD5277-8C2B-4535-AAD2-37F2CDA1C147

P2860

Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies.

http://www.wikidata.org/entity/Q36375924

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh

2006年學術文章

@zh-hant

name

Peritoneal carcinomatosis of c ...... current treatment strategies.

@ast

Peritoneal carcinomatosis of c ...... current treatment strategies.

@en

type

label

Peritoneal carcinomatosis of c ...... current treatment strategies.

@ast

Peritoneal carcinomatosis of c ...... current treatment strategies.

@en

prefLabel

Peritoneal carcinomatosis of c ...... current treatment strategies.

@ast

Peritoneal carcinomatosis of c ...... current treatment strategies.

@en

P1433

Q36375924-96CA2CBF-F9E0-4BB7-828F-A7C8DD944D8E

P1476

Q36375924-C22FF7AB-DB08-4EA6-8616-AA9DF1B6B5EC

P2093

Q36375924-2BB884AB-2537-4511-BB2F-842A20C3B209

Q36375924-32250E3C-C893-4166-9575-F8951563FB82

Q36375924-41600E97-DC27-4B75-AD04-5E4B7D87D1B3

P2860

Q36375924-021F34EF-70AD-4366-8B4A-A8BDF4869B6C

Q36375924-02646DBA-9B84-4C7B-900E-0123D17B8A2A

Q36375924-0C1A8852-C8D0-473E-9CC7-A725D8098C53

Q36375924-0DFCE4C6-D746-419E-9BD9-A2D54FC2724B

Q36375924-10475D4C-1F51-40F6-8BD8-421A3E6DE167

Q36375924-133DED57-1C85-4541-872C-354B1C8F1C79

Q36375924-166EFA3D-C08F-4A3D-AA37-806C7A2F6CD6

Q36375924-18087AC9-F594-49C9-9454-5537A21B0832

Q36375924-1A771672-FBC2-45F6-BED6-B52FE093386D

Q36375924-1D8B6420-159E-4C2E-B67F-A1BC7A017202

P304

Q36375924-90A3D9F1-02D9-4BBA-A5E2-6D7C3ED1CB8B

P31

Q36375924-24E099C1-7F54-426A-B98D-16ABBF4DBB1E

P356

Q36375924-2655AE06-349E-4B68-B676-7865AA3B544D

P407

Q36375924-54F41EA9-48D7-4AD9-8365-93CCF65D9D5B

P433

Q36375924-CA2C4129-88F5-4E76-931C-80B2BEE55A8F

P478

Q36375924-F907ACF9-2D55-48A5-8931-F93433F68128

P50

Q36375924-021C8DB1-16F1-4987-976F-8649531CF235

Q36375924-BC9A90EC-ADBC-4A56-91A8-DB9230D4DA0F

P577

Q36375924-749FF4C7-B71E-40CD-BE3E-3437AB5FE1D8

P5875

Q36375924-FB7E55F3-69C7-424A-B746-F96A7C73BFC7

P698

Q36375924-2E7399D1-D4AD-4CF1-8336-DB5D201E85D1

P932

Q36375924-E4838DAC-A95B-425F-990B-6DB640B140CB

P356

01.SLA.0000197702.46394.16

P1433

Annals of Surgery

P1476

Peritoneal carcinomatosis of c ...... current treatment strategies.

@en

P2093

Manuel J Koppe

http://www.w3.org/2001/XMLSchema#string

Robert P Bleichrodt

http://www.w3.org/2001/XMLSchema#string

Wim J G Oyen

http://www.w3.org/2001/XMLSchema#string

P2860

Management of peritoneal-surface malignancy: the surgeon's role.

Hyperthermic intraperitoneal chemoperfusion in the treatment of locally advanced intra-abdominal cancer.

Surgical debulking and intraperitoneal chemotherapy for established peritoneal metastases from colon and appendix cancer.

Surgical management of peritoneal carcinosis: diagnosis, prevention and treatment.

Quality of life as an outcome measure in surgical oncology.

Clinical delivery system for intraperitoneal hyperthermic chemotherapy.

Adjuvant therapy in colon cancer: current status and future directions.

Long-term prognostic value of conventional peritoneal cytology after curative resection for colorectal carcinoma.

Detection and clinical relevance of tumor cells in blood and bone marrow of patients with colorectal cancer.

Relevance of disseminated tumour cells in blood and bone marrow of patients with solid epithelial tumours in perspective.

P304

212-222

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/01.SLA.0000197702.46394.16

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

243

http://www.w3.org/2001/XMLSchema#string

P50

Otto C. Boerman

P577

2006-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7341557

http://www.w3.org/2001/XMLSchema#string

P698

16432354

http://www.w3.org/2001/XMLSchema#string

P932

1448921

http://www.w3.org/2001/XMLSchema#string